Serum Levels of FGF21, β-Klotho, and BDNF in Stable Coronary Artery Disease Patients With Depressive Symptoms: A Cross-Sectional Single-Center Study

Yeshun Wu; Zijun Chen; Jiahao Duan; Kai Huang; Bin Zhu; Ling Yang; Lu Zheng

doi:10.3389/fpsyt.2020.587492

Serum Levels of FGF21, β-Klotho, and BDNF in Stable Coronary Artery Disease Patients With Depressive Symptoms: A Cross-Sectional Single-Center Study

Front Psychiatry. 2021 Jan 21:11:587492. doi: 10.3389/fpsyt.2020.587492. eCollection 2020.

Authors

Yeshun Wu^{1

2}, Zijun Chen¹, Jiahao Duan¹, Kai Huang¹, Bin Zhu³, Ling Yang¹, Lu Zheng⁴

Affiliations

¹ Department of Cardiology, The Third Affiliated Hospital of Soochow University, Changzhou, China.
² Department of Cardiology, People's Hospital of Quzhou, Quzhou, China.
³ Department of Critical Care Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, China.
⁴ Comprehensive Laboratory, The Third Affiliated Hospital of Soochow University, Changzhou, China.

Abstract

Background: The incidence of depressive symptoms (DS) in patients with stable coronary artery disease (SCAD) is significantly higher than those in healthy population, and that DS are independent risk factors for cardiovascular events. Previous studies have reported that fibroblast growth factor 21 (FGF21), β-klotho, mature brain-derived neurotrophic factor (mBDNF), and BDNF precursor (proBDNF) play important roles in the pathogenesis and treatment of coronary heart disease and depression. With this in mind, the present study aimed to clarify the relationship between FGF21, β-klotho, mBDNF, and proBDNF and SCAD with comorbid depression, in addition to also exploring the underlying mechanisms of these disease processes. Methods: A total of 116 patients with SCAD and 45 healthy controls were recruited. Patients with SCAD were further divided into two subgroups based on the Zung Self-Rating Depression Scale (SDS), which were characterized as those with no DS (NDS) and those with DS. Baseline data were collected, and serum levels of FGF21, β-klotho, mBDNF, and proBDNF were determined. Results: In SCAD patients, Gensini scores-denoting the degree of coronary arteriostenosis-were significantly greater in the DS group than in the NDS group. There was also a positive correlation between the Gensini scores and the SDS scores. Patients in the SCAD group demonstrated a lower serum FGF21. Serum β-klotho, mBDNF, and mBDNF/proBDNF were also significantly lower in the DS group than in the NDS group. Furthermore, β-klotho and mBDNF were negatively correlated with the SDS scores. Additionally, SCAD patients were divided into lower- and higher-level groups using hierarchical cluster analysis, with the results highlighting that patients in the lower mBDNF group had a higher incidence of DS. Conclusions: The depression score was positively correlated with the severity of coronary artery stenosis, and serum FGF21, β-klotho, mBDNF, and proBDNF were closely related to the development of DS in patients with SCAD. These observations suggest FGF21, β-klotho, mBDNF, and proBDNF as potential diagnostic and/or therapeutic targets for SCAD with co-morbid depression.

Keywords: brain-derived neurotrophic factor; depressive symptoms; fibroblast growth factor 21; stable coronary artery disease; β-Klotho.